Ask AI
ProCE Banner Activity

Expert Guidance and Clinical Resources to Improve the Care of Patients With Mantle Cell Lymphoma

Slideset

Downloadable slideset on the current standards of care as well as clinical evidence-informed frontline and subsequent treatment approaches in mantle cell lymphoma

Released: May 19, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Target Audience

This activity is intended for hematology/oncology physician specialists and other healthcare professionals providing care for patients with mantle cell lymphoma in the United States.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Select optimal treatments for patients with treatment-naive MCL, considering expert recommendations along with available efficacy and safety evidence

  • Identify patients with MCL most likely to benefit from chemotherapy-free treatment options

  • Plan therapeutic strategies for patients with relapsed/refractory MCL based on the clinical evidence and expert guidance on current and emerging treatment options

  • Evaluate emerging evidence for novel treatment options or combinations for patients with MCL

  • Manage toxicities associated with BTK inhibitor–based therapy to support adherence, appropriate dosing, and treatment continuation for optimal patient outcomes